Global Improvement and Patient Satisfaction: Results from a Long-Term, Open-Label, Rollover Study of Valbenazine in Tardive Dyskinesia

被引：0
|
作者：
Lessig, S.
Marder, S.
Verghese, C.
Burke, J.
Jimenez, R.
Siegert, S.
Liang, G.
机构：
来源：
MOVEMENT DISORDERS | 2018年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
92
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 50 条
  • [21] Long-Term Treatment With Deutetrabenazine (DTBZ) Is Associated With Continued Improvement in Tardive Dyskinesia (TD): Results From the Completed, 3-year Open-Label Extension (OLE) Study
    Hauser, R.
    Barkay, H.
    Fernandez, H.
    Factor, S.
    Jimenez-Shahed, J.
    Gross, N.
    Marinelli, L.
    Wilhelm, A.
    Gordon, M.
    Savola, J. M.
    Anderson, K.
    MOVEMENT DISORDERS, 2020, 35 : S32 - S32
  • [22] Patterns of Improvement in Tardive Dyskinesia: Post-Hoc Analysis of a Long-Term Study with Valbenazine (KINECT 4)
    Correll, Christoph U.
    Carmack, Tara
    Shah, Chirag
    Lundt, Leslie
    ANNALS OF NEUROLOGY, 2021, 90 : S148 - S149
  • [23] Sustained Treatment Response With Long-Term Valbenazine in Patients With Tardive Dyskinesia
    Correll, Christoph U.
    Lindenmayer, Jean-Pierre
    Farahmand, Khody
    Jen, Eric
    Siegert, Scott
    Dunayevich, Eduardo
    CNS SPECTRUMS, 2023, 28 (02) : 241 - 241
  • [24] Long-term effects of valbenazine on tardive dyskinesia in patients with a mood disorder
    McIntyre, R.
    Nierenberg, A.
    Farahmand, K.
    Burke, J.
    Siegert, S.
    BIPOLAR DISORDERS, 2018, 20 : 116 - 116
  • [25] Sustained Treatment Response with Long-Term Valbenazine in Patients with Tardive Dyskinesia
    Correll, Christoph
    Lindenmayer, Jean-Pierre
    Farahmand, Khody
    Jen, Eric
    Siegert, Scott
    Dunayevich, Eduardo
    NEUROLOGY, 2023, 100 (17)
  • [26] Sustained Treatment Response With Long-Term Valbenazine in Patients With Tardive Dyskinesia
    Correll, Christoph
    Lindenmayer, Jean-Pierre
    Farah-Mand, Khodayar
    Siegert, Scott
    Dunayevich, Eduardo
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 344 - 345
  • [27] Sustained Treatment Response With Long-Term Valbenazine in Patients With Tardive Dyskinesia
    Correll, Christoph
    Lindenmayer, Jean-Pierre
    Farahmand, Khodayar
    Siegert, Scott
    Dunayevich, Eduardo
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 344 - 345
  • [28] Long-Term Effects of Valbenazine on Tardive Dyskinesia in Older and Younger Adults
    Alexopoulos, George S.
    Sajatovic, Martha
    Sheth, Bijal
    Siegert, Scott
    Farahmand, Khodayar
    Burke, Joshua
    Liang, Grace S.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2018, 26 (03): : S158 - S159
  • [29] Effects of Long-Term Valbenazine on Tardive Dyskinesia by Body Region: Shift Analyses of KINECT 4 Study Results
    Comella, C.
    Singer, C.
    Marder, S.
    Burke, J.
    Farahmand, K.
    Jimenez, R.
    Siegert, S.
    MOVEMENT DISORDERS, 2018, 33 : S37 - S37
  • [30] Long-Term Safety and Tolerability of Valbenazine in Older and Younger Adults with Tardive Dyskinesia
    Sajatovic, Martha
    Alexopoulos, George S.
    Guillory, Monica
    Farahmand, Khodayar
    Burke, Joshua
    Liang, Grace S.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2018, 26 (03): : S159 - S160
12345